ArticleBriefings in bioinformatics2026
PEPNet: a two-stage point cloud framework with hierarchical embedding and antigen-antibody interaction modeling for epitope prediction.
Article in Briefings in bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Exploring the mechanism by which triphenyl phosphate promotes malignant phenotypes in bladder and kidney cancer through MMP9 based on bioinformatics analysis and experimental validation.Clinical and experimental medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Epitope prediction is a key challenge in immunology and therapeutic antibody design. Existing computational methods rely on residue-level graph representations that fail to capture fine-grained atomic-level geometric information essential for antibody-antigen recognition. Considering that protein structure files (e.g. Protein Data Bank (PDB) files) inherently contain 3D atomic coordinates, we model proteins as atomic-level point clouds to directly preserve high-resolution spatial features . Building on this representation, we propose Point cloud-based Epitope Prediction Network(PEPNet), a two-stage point cloud framework for epitope prediction. Inspired by the natural atom-to-residue hierarchy in proteins, PEPNet employs a residue-aware hierarchical embedding module to aggregate atomic features into residue-level embeddings. To capture sequential dependencies absent in unordered point clouds, we integrate rotary positional encoding. Additionally, PEPNet leverages a BERT-style pretraining strategy with data augmentation to mitigate data scarcity, and a cross-attention decoder to explicitly model antigen-antibody interactions. Experimental results show that PEPNet achieves the best overall performance (MCC = 0.401, AUC = 0.765). Even when evaluated on AlphaFold3-predicted structures, PEPNet maintains strong robustness (MCC = 0.346), still outperforming WALLE (MCC = 0.305). These results underscore PEPNet's potential for real-world antibody-antigen analysis and design.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.